Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28,090 | $18,135 | $27,264 | $61,425 |
| - Cash | $1,135 | $861 | $578 | $630 |
| + Debt | $2,089 | $2,089 | $2,225 | $2,482 |
| Enterprise Value | $29,044 | $19,363 | $28,911 | $63,277 |
| Revenue | $3,609 | $3,512 | $3,234 | $1,681 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Gross Profit | $2,139 | $1,978 | $1,780 | $1,046 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| EBITDA | $1,159 | -$3,193 | $977 | $579 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |
| Net Income | $513 | -$3,851 | $394 | $341 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| Operating Cash Flow | $907 | $757 | $636 | $384 |
| Capital Expenditures | -$92 | -$119 | -$87 | -$62 |
| Free Cash Flow | $907 | $638 | $549 | $322 |